Evidence map›Paper›PMID 35536538›Full record

ArticleInterdisciplinary sciences, computational life sciences2022

Improving the Prediction of Potential Kinase Inhibitors with Feature Learning on Multisource Knowledge.

Yichen Zhong, Cong Shen, Huanhuan Wu, Tao Xu, Lingyun Luo

Abstract read
PubMed Publisher
In one paragraph

Article in Interdisciplinary sciences, computational life sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Yichen ZhongSchool of Computer Science, University of South China, Hengyang, 421001, China.
Cong ShenCollege of Computer Science and Electronic Engineering, Hunan University, Changsha, 410083, China.
Huanhuan WuSchool of Computer Science, University of South China, Hengyang, 421001, China.
Tao XuSchool of Computer Science, University of South China, Hengyang, 421001, China.
Lingyun LuoSchool of Computer Science, University of South China, Hengyang, 421001, China. luoly@usc.edu.cn.ORCID http://orcid.org/0000-0002-8239-9056
Department of Science and Technology of Hunan Province · CNUniversity of South China · CNHunan University · CN

Funding

Hunan Provincial Innovation Foundation for Postgraduate CX20210937Hunan Provincial Natural Science Foundation of China 2019JJ50520
6 · The paper itself

Abstract

purposeThe identification of potential kinase inhibitors plays a key role in drug discovery for treating human diseases. Currently, most existing computational methods only extract limited features such as sequence information from kinases and inhibitors. To further enhance the identification of kinase inhibitors, more features need to be leveraged. Hence, it is appealing to develop effective methods to aggregate feature information from multisource knowledge for predicting potential kinase inhibitors. In this paper, we propose a novel computational framework called FLMTS to improve the performance of kinase inhibitor prediction by aggregating multisource knowledge.

methodFLMTS uses a random walk with restart (RWR) to combine multiscale information in a heterogeneous network. We used the combined information as features of compounds and kinases and input them into random forest (RF) to predict unknown compound-kinase interactions.

resultsExperimental results reveal that FLMTS obtains significant improvement over existing state-of-the-art methods. Case studies demonstrated the reliability of FLMTS, and pathway enrichment analysis demonstrated that FLMTS could also accurately predict signaling pathways in disease treatment.

conclusionIn conclusion, our computational framework of FLMTS for improving the prediction of potential kinase inhibitors successfully aggregates feature information from multisource knowledge, yielding better prediction performance than existing state-of-the-art methods.

Indexed as

AlgorithmsComputational BiologyDrug DiscoveryHumansProtein Kinase InhibitorsReproducibility of ResultsProtein Kinase InhibitorsFeature learningHeterogeneous networkKinase inhibitorMultisource knowledge

Identifiers

PMID35536538
OpenAlexW4229458516

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.